Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
- PMID: 30425542
- PMCID: PMC6203106
- DOI: 10.2147/CEOR.S184289
Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
Conflict of interest statement
Disclosure Kaoru Yamabe is an employee of Takeda Pharmaceutical Company Limited, which funded this research. The author reports no other conflict of interest in this work.
Similar articles
-
The relationship between socio-demographic factors, health status, treatment type, and employment outcome in patients with inflammatory bowel disease in Japan.BMC Public Health. 2017 Jul 4;17(1):623. doi: 10.1186/s12889-017-4516-0. BMC Public Health. 2017. PMID: 28676039 Free PMC article.
-
The burden of multiple sclerosis in Japan.J Med Econ. 2017 Dec;20(12):1290-1298. doi: 10.1080/13696998.2017.1373653. Epub 2017 Oct 12. J Med Econ. 2017. PMID: 28849983
-
Gender differences in information needs and preferences regarding depression among individuals with multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis.Patient Educ Couns. 2019 Sep;102(9):1722-1729. doi: 10.1016/j.pec.2019.04.007. Epub 2019 Apr 6. Patient Educ Couns. 2019. PMID: 30982700
-
Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.CNS Drugs. 2018 Feb;32(2):117-133. doi: 10.1007/s40263-018-0489-5. CNS Drugs. 2018. PMID: 29417493 Review.
-
The economic burden of depression in the US: societal and patient perspectives.Expert Opin Pharmacother. 2005 Mar;6(3):369-76. doi: 10.1517/14656566.6.3.369. Expert Opin Pharmacother. 2005. PMID: 15794728 Review.
References
-
- Kantar Health . Patient-Reported Healthcare Insights. New York: Kantar Health; [Accessed July 25, 2018]. National Health and Wellness Survey. Available from: http://www.kantarhealth.com/docs/datasheets/kh-national-health-andwellne....
Publication types
LinkOut - more resources
Full Text Sources